143 related articles for article (PubMed ID: 8652775)
21. In vivo evaluation of Vivere bovine pericardium valvular bioprosthesis with a new anti-calcifying treatment.
Braile-Sternieri MCVB; Goissis G; Giglioti AF; Ramirez VDA; Pereira NP; de Vasconcellos A; Basso-Frazzato GG; Braile DM
Artif Organs; 2020 Nov; 44(11):E482-E493. PubMed ID: 32364253
[TBL] [Abstract][Full Text] [Related]
22. Prevention of calcification with TPEN in pericardial bioprosthetic heart valve material.
Döndaş HA; Yilmaz N; Cömelekoğlu U; Tamer L; Sucu N; Aytaçoğlu BN; Ozeren M; Köse N; Dikmengil M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):365-70. PubMed ID: 18065330
[TBL] [Abstract][Full Text] [Related]
23. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
[TBL] [Abstract][Full Text] [Related]
24. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
Weissenstein C; Human P; Bezuidenhout D; Zilla P
J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
[TBL] [Abstract][Full Text] [Related]
25. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model.
Pettenazzo E; Valente M; Thiene G
Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382
[TBL] [Abstract][Full Text] [Related]
26. Synergistic inhibition of the calcification of glutaraldehyde pretreated bovine pericardium in a rat subdermal model by FeCl3 and ethanehydroxydiphosphonate: preincubation and polymeric controlled release studies.
Hirsch D; Drader J; Pathak YV; Yee R; Schoen FJ; Levy RJ
Biomaterials; 1993 Jul; 14(9):705-11. PubMed ID: 8399967
[TBL] [Abstract][Full Text] [Related]
27. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses.
Golomb G; Schoen FJ; Smith MS; Linden J; Dixon M; Levy RJ
Am J Pathol; 1987 Apr; 127(1):122-30. PubMed ID: 3105321
[TBL] [Abstract][Full Text] [Related]
28. Effect of ethanol and ether in the prevention of calcification of bioprostheses.
Shen M; Kara-Mostefa A; Chen L; Daudon M; Thevenin M; Lacour B; Carpentier A
Ann Thorac Surg; 2001 May; 71(5 Suppl):S413-6. PubMed ID: 11388238
[TBL] [Abstract][Full Text] [Related]
29. Improved biocompatibility of bioprosthetic heart valves by L-glutamic acid treatment.
Grimm M; Grabenwöger M; Eybl E; Moritz A; Böck P; Müller MM; Wolner E
J Card Surg; 1992 Mar; 7(1):58-64. PubMed ID: 1348195
[TBL] [Abstract][Full Text] [Related]
30. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium.
Lim HG; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Feb; 41(2):383-90. PubMed ID: 21683607
[TBL] [Abstract][Full Text] [Related]
31. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model.
Valente M; Pettenazzo E; Thiene G; Molin GM; Martignago F; De Giorgi G; Gatti AM; Giaretta A; Pasquino E; Talenti E; Rinaldi S
J Heart Valve Dis; 1998 May; 7(3):283-91. PubMed ID: 9651841
[TBL] [Abstract][Full Text] [Related]
32. Effects of metallic ions and diphosphonates on inhibition of pericardial bioprosthetic tissue calcification and associated alkaline phosphatase activity.
Hirsch D; Schoen FJ; Levy RJ
Biomaterials; 1993 Apr; 14(5):371-7. PubMed ID: 8507781
[TBL] [Abstract][Full Text] [Related]
33. Anticalcification treatment of pericardial prostheses.
Chanda J
Biomaterials; 1994 May; 15(6):465-9. PubMed ID: 8080938
[TBL] [Abstract][Full Text] [Related]
34. Diphenylhydantoin inhibits calcification of bovine pericardial implants and myocardium: a preliminary study.
Liao K; Seifter E; Factor SM; Yellin EL; Frater RW
J Surg Res; 1992 Oct; 53(4):349-56. PubMed ID: 1405616
[TBL] [Abstract][Full Text] [Related]
35. Advanced Integrity Preservation Technology Reduces Bioprosthesis Calcification While Preserving Performance and Safety.
De La Fuente AB; Wright GA; Olin JM; Duhay FG; Kapelak B; Bochenek M; Bartus K; Sadowski J
J Heart Valve Dis; 2015 Jan; 24(1):101-9. PubMed ID: 26182627
[TBL] [Abstract][Full Text] [Related]
36. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.
Zhou J; Jiang H; Wang D; Hu S
J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893
[TBL] [Abstract][Full Text] [Related]
37. Prevention of calcification of heart valve bioprostheses: an experimental study in rat.
Chanda J
Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S339-42. PubMed ID: 7646184
[TBL] [Abstract][Full Text] [Related]
38. Effect of delay between tissue harvest and glutaraldehyde pretreatment on mineralization of bovine pericardium used in bioprosthetic heart valves.
Maranto AR; Schoen FJ
J Biomed Mater Res; 1988 Sep; 22(9):819-25. PubMed ID: 3146571
[TBL] [Abstract][Full Text] [Related]
39. Heat treatment mitigates calcification of valvular bioprostheses.
Carpentier SM; Chen L; Shen M; Fornes P; Martinet B; Quintero LJ; Witzel TH; Carpentier AF
Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S264-6. PubMed ID: 9930461
[TBL] [Abstract][Full Text] [Related]
40. Lipid extraction attenuates the calcific degeneration of bovine pericardium used in cardiac valve bioprostheses.
Rossi MA; Braile DM; Teixeira MD; Souza DR; Peres LC
J Exp Pathol (Oxford); 1990 Apr; 71(2):187-96. PubMed ID: 2331406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
